Carina Biotech
PrivateLast Round
Early Funding
Apr 15, 2025
Total Funding Raised
$14.58M
Company Overview
Carina Biotech is a biotechnology company that researches and develops chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Carina Biotech Comps
Public and private peers based on sector, stage, and business model.
Carina Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 15, 2025 | ||||
| Series A | Aug 15, 2022 | ||||
| Early Funding | Sep 1, 2021 | ||||
| Grant | Apr 23, 2020 |
Carina Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Minderoo Foundation | Series A, Early Funding |
| University of Adelaide | Series A |
| Tenmile | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 22, 2025
Grew 19% QoQ, from 16 to 19 employees.
- Nov 14, 2025
Monthly visitors increased 101% MoM.
Carina Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Carina Biotech's valuation, stock price, and market status.
